Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Fidelity Medical Clinic vs Hims & Hers

Fidelity Medical Clinic
Graded #137

Lower grade

vs+12.299999999999997
Hims & Hers
Graded #36

Higher grade

The verdict

Hims & Hers takes it — 81/100 to 68.7/100.

Hims & Hers grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Mass-market app-first program with nationwide reach and consumer-grade polish.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueFidelity Medical Clinic +2
84
82
Dose & formulationHims & Hers +15
63
78
Clinical oversightHims & Hers +13
69
82
Labs & monitoringHims & Hers +28
52
80
FulfillmentHims & Hers +8
76
84
Contract termsHims & Hers +25
55
80
Fidelity Medical Clinic · left barHims & Hers · right bar

The numbers

MetricFidelity Medical ClinicHims & Hers
WeighScore68.7/10081/100
GradeCB−
Scorecard rank#137#36
Semaglutide$99/mo (starting dose, compounded)$199/mo
TirzepatideNot disclosedNot disclosed
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
Fidelity Medical Clinic

Graded #137 · C

Strengths

  • Low-cost compounded semaglutide and tirzepatide from $99/month
  • Injectable or oral options with a free telehealth consultation
  • Ships nationally; clinic-plus-telehealth hybrid

Where it loses points

  • Compounded GLP-1s are not FDA-approved finished products
  • Local Tampa clinic with national telehealth — experience may vary
  • Public state list is not enumerated
  • Cash-pay model
Hims & Hers

Graded #36 · B−

Strengths

  • Nationwide
  • Polished app
  • Strong brand trust

Where it loses points

  • Tirzepatide pricing inconsistently disclosed
  • Industry-wide compounding scrutiny

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard